Corza Medical, a portfolio company of private equity firm GTCR, has acquired Katena Products, Inc., a medical device company focused on ophthalmic surgery products.

Katena is a provider of ophthalmic products used in surgeries for cataracts, glaucoma and cornea repair. The firm’s products include precision surgical instruments, single-use devices and specialty devices sold to 5,000 medical customers across 110 countries.

The deal will expand Corza’s surgical product offering and increases scale and infrastructure to Corza’s existing surgery segment. This is Corza’s first acquisition since its formation in 2021 as a result of a merger following the carve-out of Takeda Pharmaceutical.

“Katena is a brand with decades of trust and clinical relevance in ophthalmic surgery,” said Dan Croteau, CEO of Corza. “Corza is committed to providing exceptional service and value to our customers, transforming surgical outcomes and changing the lives of patients around the globe. “

William Blair acted as financial advisor and Latham & Watkins provided legal counsel to Corza and GTCR.